Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Killing the messenger: antisense DNA and siRNA.

M Nesterova1, Y S Cho-Chung

  • 1Cellular Biochem. Section, BRL, CCR, National Cancer Institute, Head, NIH Therapeutic Oligo. Int. Group, Bldg. 10, Rm. 5B05, 9000 Rockville Pike, Bethesda, MD 20892-1750, USA.

Current Drug Targets
|December 8, 2004
PubMed
Summary

RNase H-dependent antisense oligonucleotides and RNA interference (RNAi) are key gene knockdown technologies. This review covers their development, challenges like delivery and toxicity, and potential for gene-silencing therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not all glucocorticoid-induced obesity is the same: differences in adiposity among various diagnostic groups of Cushing syndrome.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Threat bias in mice with inactivating mutations of Prkar1a.

Neuroscience·2013
Same author

PRKAR1A gene analysis and protein kinase A activity in endometrial tumors.

Endocrine-related cancer·2012
Same author

Comparison of aldosterone production among human adrenocortical cell lines.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2012
Same author

Protein kinase-a directed antisense therapy of tumor growth in vivo : the antisense effects outlast antisense survival.

Methods in molecular medicine·2011

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Therapeutic Technologies

Background:

  • RNase H-dependent antisense oligonucleotides and RNA interference (RNAi) are prominent gene knockdown technologies.
  • Both methods provide specific and efficient gene silencing, valuable for functional genomics research.
  • Despite their utility, challenges persist, including optimal site selection, potential toxicity, and transfection difficulties.

Purpose of the Study:

  • To review the critical issues in the development of antisense oligonucleotide and RNAi technologies.
  • To explore the potential applications of these gene knockdown methods in therapeutic gene silencing.

Main Methods:

  • Literature review focusing on RNase H-dependent antisense oligonucleotides and RNAi.
  • Analysis of common challenges in gene knockdown technology development.

Related Experiment Videos

  • Assessment of gene-silencing therapy potential.

    • Main Results:

    • Antisense and RNAi technologies offer specific gene knockdown but face shared hurdles.
    • Key challenges include target site selection, dose-dependent toxicity, and cell-type-specific transfection efficiency.
    • Significant progress has been made in overcoming these obstacles for therapeutic applications.

    Conclusions:

    • Antisense oligonucleotides and RNAi are powerful tools for gene function studies and therapeutic development.
    • Addressing challenges in delivery, specificity, and safety is crucial for advancing gene-silencing therapies.
    • Further research holds promise for the clinical translation of these gene knockdown strategies.